Free Trial

Conduit Pharmaceuticals (CDT) Insider Trading & Ownership

Conduit Pharmaceuticals logo
$0.14 +0.05 (+56.55%)
(As of 09:46 AM ET)

Conduit Pharmaceuticals (NASDAQ:CDT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
34.74%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$1.45 M
Get CDT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Conduit Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CDT Insider Buying and Selling by Quarter

Conduit Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/7/2024Ltd NirlandMajor ShareholderSell939,009$0.10$93,900.90  
10/4/2024Ltd NirlandMajor ShareholderSell1,368,991$0.10$136,899.10  
10/2/2024Ltd NirlandMajor ShareholderSell333,177$0.10$33,317.70  
9/30/2024Ltd NirlandMajor ShareholderSell1,016,823$0.12$122,018.76  
7/17/2024Andrew ReganDirectorSell1,514,100$0.26$393,666.00  
7/15/2024Andrew ReganDirectorSell1,005,200$0.25$251,300.00  
7/12/2024Andrew ReganDirectorSell1,389,820$0.25$347,455.00  
7/10/2024Andrew ReganDirectorSell150,000$0.33$49,500.00  
7/8/2024Andrew ReganDirectorSell35,923$0.51$18,320.73  
7/3/2024Andrew ReganDirectorSell1,000$0.64$640.00  
(Data available from 1/1/2013 forward)

CDT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Conduit Pharmaceuticals includes Andrew Regan, and Ltd Nirland. Learn more on insiders at CDT.

34.74% of Conduit Pharmaceuticals stock is owned by insiders. Learn more on CDT's insider holdings.

The following insiders have sold CDT shares in the last 24 months: Andrew Regan ($1,060,881.73), and Ltd Nirland ($386,136.46).

Insiders have sold a total of 7,754,043 Conduit Pharmaceuticals shares in the last 24 months for a total of $1,447,018.19 sold.

Conduit Pharmaceuticals Key Executives

  • Dr. David Joszef Tapolczay (Age 65)
    CEO & Director
    Compensation: $419.8k
  • Mr. Adam Sragovicz (Age 54)
    Chief Financial Officer
    Compensation: $116.67k
  • Dr. Joanne M. Holland (Age 49)
    Chief Scientific Officer


This page (NASDAQ:CDT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners